NCT07394621

Brief Summary

The goal of this prospective and cross-sectional observational study is to learn if the presence and changes in kinesiofobia (fear of movement) affect functional capacity levels in heart failure patients who are transplant candidates and have been implanted with a Left Ventricular Assist Device (LVAD). The main questions it aims to answer are: i) Does the level of kinesiofobia change significantly 1 month after LVAD implantation? ii) Do changes in kinesiofobia levels predict changes in functional exercise capacity (measured by the 2-Minute Walk Test and 30-Second Sit-to-Stand Test)? Researchers will compare pre-discharge (baseline) measurements to 1-month post-discharge follow-up measurements to see if improvements in kinesiofobia correlate with improved functional mobility and endurance. Participants will: i) Complete the Tampa Scale of Kinesiofobia (TSK) to assess their fear of movement. ii) Perform the 2-Minute Walk Test (2MWT) to evaluate functional exercise capacity and mobility. iii) Perform the 30-Second Sit-to-Stand Test (30STS) to determine functional endurance and lower extremity performance. iv) Receive standardized physical activity recommendations upon discharge. v) Return for a follow-up assessment one month later to repeat the same battery of tests.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2026

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

January 30, 2026

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 6, 2026

Completed
Last Updated

February 10, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

January 30, 2026

Last Update Submit

February 6, 2026

Conditions

Keywords

kinesiophobiafunctional capacityLVAD

Outcome Measures

Primary Outcomes (1)

  • Tampa Kinesiophobia Scale

    The Tampa Scale of Kinesiofobia (TSK) is a widely used patient-reported outcome measure designed to quantify a patient's fear of movement and fear of (re)injury. It was originally developed to assess patients with chronic low back pain, but it has since been validated for various populations. It is a 17-item questionnaire where each item is scored on a 4-point Likert scale, ranging from "strongly disagree" to "strongly agree". While cut-off values can vary by population, a score higher than 37 is often considered to represent high kinesiofobia.

    From enrollment to the 4 weeks after the implementation

Secondary Outcomes (2)

  • 2-Minute Walk Test

    From enrollment to the 4 weeks after the implementation

  • 30 Seconds Sit to Stand Test (30STS)

    From enrollment to the 4 weeks after the implementation

Study Arms (1)

Exercise Recommendation Group

EXPERIMENTAL

Patient who recevied physical activity recommendations after LVAD implementation

Diagnostic Test: Physical Activity Recommandations

Interventions

Patients with implanted LVADs will be given recommendations for physical activities they can incorporate into their daily lives.

Also known as: 30 seconds sit to stand test, 2 minute walk test
Exercise Recommendation Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Being a heart transplant candidate and having undergone LVAD implantation,
  • Having a left ventricular ejection fraction (LVEF) \<30%,
  • Not having developed any surgical or medical complications in the early period after implantation,
  • Being referred to the study by a cardiologist at the time of discharge,
  • Being able to read and write and volunteering to participate in the study.

You may not qualify if:

  • Those with evidence of active infection following implantation,
  • Psychiatric problems developing after LVAD implantation that interfere with cognitive adaptation,
  • Musculoskeletal problems developing after LVAD implantation,
  • Cases experiencing acute cardiac problems requiring hospitalization during follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University Faculty of Health Sciences

Istanbul, 34854, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Kinesiophobia

Interventions

Walk Test

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Exercise TestHeart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Rafet Umut Erdoğan

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

January 30, 2026

First Posted

February 6, 2026

Study Start

December 2, 2024

Primary Completion

January 4, 2026

Study Completion

February 4, 2026

Last Updated

February 10, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations